Literature DB >> 2149257

The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy.

T M Reynolds1, M D Penney.   

Abstract

The underlying mathematical techniques behind the multivariate normal distribution are explained in principle and expanded in detail for up to three variables. The application of multivariate distributions to screening programs is described with particular reference to the calculation of risk ratios for the detection of Down's syndrome between 15 and 19 weeks of gestation.

Mesh：

Year:  1990        PMID： 2149257     DOI： 10.1177/000456329002700506

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


  19 in total

1.  Estimations of gestational age and screening for Down's syndrome.

Authors:  T M Reynolds; M D Penney
Journal:  BMJ       Date:  1991-05-18

2.  Medians for second-trimester maternal serum markers: geographical differences and variation caused by median multiples-of-median equations.

Authors:  G Vranken; T Reynolds; J Van Nueten
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

3.  Serum screening for Down's syndrome. Private screening is problematic.

Authors:  T M Reynolds
Journal:  BMJ       Date:  1993-08-21

Review 4.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 5.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

6.  Weight correction of MoM values: which method?

Authors:  T M Reynolds; G Vranken; J Van Nueten
Journal:  J Clin Pathol       Date:  2006-04-07       Impact factor: 3.411

7.  Saving and empowering young lives in Europe (SEYLE): a randomized controlled trial.

Authors:  Danuta Wasserman; Vladimir Carli; Camilla Wasserman; Alan Apter; Judit Balazs; Julia Bobes; Renata Bracale; Romuald Brunner; Cendrine Bursztein-Lipsicas; Paul Corcoran; Doina Cosman; Tony Durkee; Dana Feldman; Julia Gadoros; Francis Guillemin; Christian Haring; Jean-Pierre Kahn; Michael Kaess; Helen Keeley; Dragan Marusic; Bogdan Nemes; Vita Postuvan; Stella Reiter-Theil; Franz Resch; Pilar Sáiz; Marco Sarchiapone; Merike Sisask; Airi Varnik; Christina W Hoven
Journal:  BMC Public Health       Date:  2010-04-13       Impact factor: 3.295

8.  Prenatal screening for trisomy 18 with free beta human chorionic gonadotrophin as a marker.

Authors:  K Spencer; A S Mallard; E J Coombes; J N Macri
Journal:  BMJ       Date:  1993-12-04

9.  Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.

Authors:  K Spencer; P Carpenter
Journal:  BMJ       Date:  1993-09-25

10.  Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.

Authors:  P T Dick
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.